Douglas J. Marchant

1.4k citations
53 papers · 1.1k indexed · h-index 15
Topics
Breast Cancer Treatment Studies (13 papers)Breast Lesions and Carcinomas (11 papers)Global Cancer Incidence and Screening (9 papers)
Partner nations
United States

In The Last Decade

Douglas J. Marchant

48 papers receiving 1.0k citations

Peers

Douglas J. Marchant
Comparison fields: 5 of 87
  • Cancer Research 591
  • Pathology and Forensic Medicine 424
  • Surgery 322
  • Oncology 268
  • Obstetrics and Gynecology 109
Replace Alan C. Winfield with:
Alan C. Winfield United States
Marina Bortul Italy
Maja Primic‐Žakelj Slovenia
Ines Buccimazza South Africa
Kathie‐Ann Joseph United States
Ulrich K. Henschke United States
J.A. van Dongen Netherlands
Marvin J. López United States
Chan‐Chao ChangChien Taiwan
Tim Dudderidge United Kingdom
Douglas J. Marchant relative to Alan C. Winfield United States Alan C. Winfield's profile →
Citations per field
00.5×
Alan C. Winfield · 1×
Citations per year

Countries citing papers authored by Douglas J. Marchant

Since Specialization
Citations

This map shows the geographic impact of Douglas J. Marchant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J. Marchant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J. Marchant more than expected).

Fields of papers citing papers by Douglas J. Marchant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas J. Marchant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J. Marchant. The network helps show where Douglas J. Marchant may publish in the future.

Co-authorship network of co-authors of Douglas J. Marchant

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas J. Marchant. A scholar is included among the top collaborators of Douglas J. Marchant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas J. Marchant. Douglas J. Marchant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 11
2 73
3 23
4
Weekly high-dose paclitaxel in metastatic and locally advanced breast cancer: a preliminary report.
28
5 15
6 75
7 13
8 78
9 4
10 24
11 48
12 294
13 19
14 13
15 100
16 4
17 4
18
Breast disease : proceedings of an international symposium, May 13-17, 1978
1
19 19
20 2

About Douglas J. Marchant

Douglas J. Marchant is a scholar working on Cancer Research, Obstetrics and Gynecology and Transplantation, having authored 53 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (11 papers) and Global Cancer Incidence and Screening (9 papers). The work is most often cited by research in Cancer Research (591 citations), Pathology and Forensic Medicine (424 citations) and Obstetrics and Gynecology (109 citations). Douglas J. Marchant has collaborated with scholars based in United States. Frequent co-authors include Thomas J. Smith, Rupert Schmidt‐Ullrich, David E. Wazer, Nicholas J. Robert, Thomas A. DiPetrillo, Leisa Weld, Christopher H. Schmid, Homa Safaii, George W. Mitchell and Michael Homer. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026